Diana Agostini-Vulaj

Dr. Diana Agostini-Vulaj

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SVSara A. Väyrynen
Sara A. Väyrynen
JZJinming Zhang
Jinming Zhang
CYChen Yuan
Chen Yuan
JVJuha P. Väyrynen
Juha P. Väyrynen
ACAndressa Dias Costa
Andressa Dias Costa
BWBrian M. Wolpin
Brian M. Wolpin
Purpose: Although abundant myeloid cell populations in the pancreatic ductal adenocarcinoma (PDAC) microenvironment have been postulated to suppress antitumor immunity, the composition of these populations, their spatial locations, and how they relate to patient outcomes are poorly understood.Experimental Design: To generate spatially resolved tumor and immune cell data at single-cell resolution, we developed two quantitative multiplex immunofluorescence assays to interrogate myeloid cells (CD15, CD14, ARG1, CD33, HLA-DR) and macrophages [CD68, CD163, CD86, IFN regulatory factor 5, MRC1 (CD206)] in the PDAC tumor microenvironment. Spatial point pattern analyses were conducted to assess the degree of colocalization between tumor cells and immune cells. Multivariable-adjusted Cox proportional hazards regression was used to assess associations with patient outcomes.Results: In a multi-institutional cohort of 305 primary PDAC resection specimens, myeloid cells were abundant, enriched within stromal regions, highly heterogeneous across tumors, and differed by somatic genotype. High densities of CD15+ARG1+ immunosuppressive granulocytic cells and M2-polarized macrophages were associated with worse patient survival. Moreover, beyond cell density, closer proximity of M2-polarized macrophages to tumor cells was strongly associated with disease-free survival, revealing the clinical significance and biologic importance of immune cell localization within tumor areas.Conclusions: A diverse set of myeloid cells are present within the PDAC tumor microenvironment and are distributed heterogeneously across patient tumors. Not only the densities but also the spatial locations of myeloid immune cells are associated with patient outcomes, highlighting the potential role of spatially resolved myeloid cell subtypes as quantitative biomarkers for PDAC prognosis and therapy.

21 July 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
GAGloria Asantewaa
Gloria Asantewaa
ETEmily T Tuttle
Emily T Tuttle
NWNathan P Ward
Nathan P Ward
YKYun Pyo Kang
Yun Pyo Kang
YKYumi Kim
Yumi Kim
IHIsaac S Harris
Isaac S Harris
Cells rely on antioxidants to survive. The most abundant antioxidant is glutathione (GSH). The synthesis of GSH is non-redundantly controlled by the glutamate-cysteine ligase catalytic subunit (GCLC). GSH imbalance is implicated in many diseases, but the requirement for GSH in adult tissues is unclear. To interrogate this, we have developed a series of in vivo models to induce Gclc deletion in adult animals. We find that GSH is essential to lipid abundance in vivo. GSH levels are highest in liver tissue, which is also a hub for lipid production. While the loss of GSH does not cause liver failure, it decreases lipogenic enzyme expression, circulating triglyceride levels, and fat stores. Mechanistically, we find that GSH promotes lipid abundance by repressing NRF2, a transcription factor induced by oxidative stress. These studies identify GSH as a fulcrum in the liver’s balance of redox buffering and triglyceride production.

12 February 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
LALindsay Alpert
Lindsay Alpert
RARam Al-Sabti
Ram Al-Sabti
RGRondell P. Graham
Rondell P. Graham
RGRaul S. Gonzalez
Raul S. Gonzalez
XZXuefeng Zhang
Xuefeng Zhang
MBMary P. Bronner
Mary P. Bronner

23 April 2021 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
PBPhoenix D. Bell
Phoenix D. Bell
AHAaron R. Huber
Aaron R. Huber
DADiana Agostini-Vulaj
Diana Agostini-Vulaj
Background: Small cell neuroendocrine carcinoma of the prostate (SCNECP) is a rare, aggressive subtype of prostate carcinoma. Most SCNECP arise from conventional prostate adenocarcinoma (CPAC) treated with androgen deprivation therapy (ADT). Case presentations: We identified four cases of CPAC treated with ADT, which evolved to SCNECP with liver metastasis. The average interval between the diagnosis of CPAC and SCNECP was 102 months (range: 12 to 168). Histologically, the tumors showed nests of cells with high nuclear:cytoplasmic ratios, granular chromatin, and frequent mitoses. All cases were synaptophysin, chromogranin, and AE1/AE3 positive, with a Ki-67 labeling index ≥70%. NKX3.1 was negative in all but one case and TTF-1 was positive in half. Weak ERG positivity by IHC was seen in one case which also demonstrated the TMPRSS2-ERG gene rearrangement; all other cases were negative for ERG by IHC. Serum prostate specific antigen (PSA) levels were normal to near-normal in all. The median interval between the diagnosis of SCNECP and death was 3.25 months (range: 0.75 to 26). Conclusions: Our case series highlights the importance of considering a prostate primary, even in the setting of normal PSA levels and loss of prostate markers, when diagnosing neuroendocrine carcinoma in the liver. Further, we emphasize the significance of diagnosing SCNECP that metastasizes to the liver, as it portends a particularly dismal prognosis.

29 December 2020 in Hepatic Oncology
Verified
Journal Article
Open access
NNNumbereye Numbere
Numbereye Numbere
DZDongwei Zhang
Dongwei Zhang
DADiana Agostini-Vulaj
Diana Agostini-Vulaj
Worldwide, primary liver cancer is the fourth leading cause of cancer mortality. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Sarcomatoid hepatocellular carcinoma...

1 February 2024 in Human Pathology
Verified
Journal Article
Closed access
ICIrene Y. Chen
Irene Y. Chen
MEMark G. Ettel
Mark G. Ettel
PBPhoenix D. Bell
Phoenix D. Bell
AHAaron R. Huber
Aaron R. Huber
JFJennifer J. Findeis-Hosey
Jennifer J. Findeis-Hosey
DADiana Agostini-Vulaj
Diana Agostini-Vulaj